Healthcare / Health Information ServicesKOSDAQ
$547.00
-22.00 (-3.87%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 22%
FCF escenarios
weak_data · normalized FCF $2.0B · quality 48.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$31.4B
P/E
12.2x
↓EV/EBITDA
12.6x
↑ROE
5.2%
↑Gross Margin
100.0%
↑Debt/Equity
0.15
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.3%
FCF CAGR
—
FCF margin
-5.2%
FCF / Net income
-1.30x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $64.98B · net income $2.59B · FCF $-3.36B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $64.98B | $64.98B | $59.69B | $55.10B | $48.47B |
| Net Income | $2.59B | $2.59B | $3.84B | $5.56B | $3.93B |
| EBITDA | $2.36B | $2.36B | $5.15B | $7.33B | $5.21B |
| EPS | 45.00 | 45.00 | 68.00 | 100.00 | 73.00 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 2.1% | 2.1% | 6.1% | 11.3% | 9.9% |
| Net Margin | 4.0% | 4.0% | 6.4% | 10.1% | 8.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.15 | 0.15 | 0.12 | 0.15 | 0.22 |
| Current Ratio | 1.00 | 1.00 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-3.36B | $-3.36B | $1.97B | $3.29B | $1.26B |
| Returns | |||||
| ROE | 5.2% | 5.2% | 8.2% | 13.2% | 10.9% |
| Valuation | |||||
| P/E | 12.16 | 12.16 | 17.62 | 12.36 | 15.62 |
| EV/EBITDA | 12.60 | 12.60 | 11.84 | 9.28 | 12.01 |
| P/B | 0.64 | 0.64 | 1.44 | 1.63 | 1.70 |
| Growth & Yield | |||||
| Revenue Growth | 8.9% | 8.9% | 8.3% | 13.7% | — |
| EPS Growth | -33.8% | -33.8% | -32.0% | 37.0% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
2.6%
EPS terminal req.
$48.54
Spread vs growth
-36.4%
5Y implied EPS CAGR
5.5%
EPS terminal req.
$58.73
Spread vs growth
-39.3%
10Y implied EPS CAGR
7.7%
EPS terminal req.
$94.59
Spread vs growth
-41.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-44.8%
Start / end P/E
15.1x → 12.2x
EPS bridge
68.00 → 45.00
Residual
+6.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.